PDFHydromorphone for Opioid Use Disorder
Early results of an Australian clinical trial of parenteral hydromorphone for Opioid Use Disorder.
Session date: May 22, 2024All links are direct pdf downloads of ECHO session presentations unless specified.
These files are provided for information only and are not intended to replace the clinical judgement of a practitioner. They should not be used alone to guide individual patient care.
Early results of an Australian clinical trial of parenteral hydromorphone for Opioid Use Disorder.
Session date: May 22, 2024A discussion of the evidence for the use of hydromorphone as opioid agonist therapy.
Session date: August 19, 2020